Multiple Sclerosis News

Promising New Therapy For MS Patients

Sun, 22 Jun 2008 21:40:06 GMT

An article posted early online from the Archive of Neurologyreports on a promising new treatment for people with multiple sclerosis(MS).

Full text

DioGenix Discovers Gene Sets Which Correlate To Multiple Sclerosis

Sun, 22 Jun 2008 21:40:05 GMT

Ore Pharmaceuticals Inc. (NASDAQ:ORXED) announced that DioGenix, its molecular diagnostics subsidiary, has identified novel sets of genes that it believes will form the basis of a new assay to diagnose multiple sclerosis (MS), a disease of the central nervous system (CNS).

Full text

HiCy Drug Regimen Reverses MS Symptoms In Selected Patients

Sun, 22 Jun 2008 21:40:03 GMT

A short-term, very-high dose regimen of the immune-suppressing drug cyclophosphamide seems to slow progression of multiple sclerosis (MS) in most of a small group of patients studied and may even restore neurological function lost to the disease, Johns Hopkins researchers report.

Full text

Significant Barriers Prevent People With MS From Fully Committing To Treatment Regimen, New Survey Reveals

Sat, 21 Jun 2008 18:20:05 GMT

Nearly all people (97 percent) with multiple sclerosis (MS) who have started treatment say their commitment to managing their disease in every way possible is their prime motivation for staying on therapy, according to a new North American survey of people with MS, results of which were released today at the Consortium of Multiple Sclerosis Centers annual meeting in Denver.

Full text

Bayer Schering Pharma Starts Global Awareness Campaign - Mastering MS

Fri, 20 Jun 2008 14:20:08 GMT

The results of an international survey presentedby Bayer Schering Pharma shows that many people face the same fears andconcerns when they are first diagnosed with multiple sclerosis (MS).

Full text

FTY720 Trial Continues Despite Death, UK

Fri, 20 Jun 2008 14:20:04 GMT

Drug manufacturer Novartis has reported that two people with MS taking the oral drug fingolimod (FTY720) in clinical trials experienced problems with infections, leading to a fatality in one case.

Full text

MS Society Announces Media Award Winners, Canada

Fri, 20 Jun 2008 14:20:03 GMT

The Multiple Sclerosis Society of Canada announced the winners of its annual John Alexander Media Awards, recognizing excellence in print and broadcast journalism.

Full text

EXTAVIA Approved In European Union For Treatment Of Multiple Sclerosis, First In Planned Portfolio Of Therapies From Novartis

Wed, 18 Jun 2008 07:20:52 GMT

The European Commission has approved Extavia (interferon beta-1b) for the treatment of early and relapsing forms of multiple sclerosis (MS) - the first in a new portfolio of medicines from Novartis that is planned to include both established treatments and innovative therapies for patients with MS.

Full text

MS Society Co-Funding Physio Posts To Meet Demand, UK

Wed, 18 Jun 2008 07:20:49 GMT

The MS Society is funding specialist MS physiotherapist posts to meet a need demonstrated by people living with multiple sclerosis (MS), and to combat NHS cuts.

Full text

Multiple Sclerosis Activity May Be Affected By Prozac

Tue, 17 Jun 2008 04:00:08 GMT

A new study published in the Journal ofNeurology Neurosurgery and Psychiatry finds that Prozac, acommonly prescribed antidepressant, may be an agent in slowingdown the disease process of the relapsing remitting form of multiplesclerosis (MS).

Full text